BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2679070)

  • 1. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
    Büller HR; ten Cate JW
    Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III deficiency: clinical relevance and replacement therapy.
    Gallus AS
    Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lu Z; Wang F; Liang M
    Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
    Winter JH; Fenech A; Bennett B; Douglas AS
    Br J Haematol; 1981 Nov; 49(3):449-53. PubMed ID: 7295588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
    Fourrier F; Chopin C; Goudemand J; Hendrycx S; Caron C; Rime A; Marey A; Lestavel P
    Chest; 1992 Mar; 101(3):816-23. PubMed ID: 1531791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal antithrombin III deficiency.
    Manco-Johnson MJ
    Am J Med; 1989 Sep; 87(3B):49S-52S. PubMed ID: 2679071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antithrombin III deficiency in blood donors selected for personal or familial history of venous thrombosis.
    Finazzi G; Radice E; Armato A; Barbui T
    Ric Clin Lab; 1985; 15(2):173-6. PubMed ID: 4059797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects].
    de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C
    Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
    Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
    Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency.
    Nishimura Y; Takagi Y
    Ann Thorac Cardiovasc Surg; 2018 Aug; 24(4):187-192. PubMed ID: 29681597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND; Paule P; Toohey J; Hung E; Alikhani S; Darwish R; Pahl MV
    Arch Intern Med; 1984 Sep; 144(9):1802-3. PubMed ID: 6477000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency--a feasibility pilot study.
    Kreuz WD; Schneider W; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S187-91. PubMed ID: 10650867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders].
    Ribeiro AA; Lourenço DM; Toledo CF; Noguti MA; Borges DR
    Rev Assoc Med Bras (1992); 1997; 43(3):189-94. PubMed ID: 9497544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
    Lourenço DM; Noguti MA; Juliano L
    Rev Assoc Med Bras (1992); 1995; 41(6):373-8. PubMed ID: 8733245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired antithrombin III deficiency: replacement with antithrombin III concentrates in a patient with protein S deficiency accelerates response to therapy.
    Humphries JE
    Acta Haematol; 1993; 90(3):151-4. PubMed ID: 8291376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
    St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
    J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous surgery in patients with congenital antithrombin III deficiency.
    Kelly MD; Rosenfeld D; Leslie GJ
    Aust N Z J Surg; 1994 Dec; 64(12):865-8. PubMed ID: 7980265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.